All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction
- PMID: 16912305
- PMCID: PMC1563890
- DOI: 10.1128/JVI.00688-06
All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction
Abstract
Recent studies have revealed the contribution of TRIM5alpha to retrovirus restriction in cells from a variety of primate species. TRIM5alpha consists of a tripartite motif (the RBCC domain) followed by a B30.2 domain. The B30.2 domain is thought to be involved in determination of restriction specificity and contains three variable regions. To investigate the relationship between the phylogeny of primate TRIM5alpha and retrovirus restriction specificity, a series of chimeric TRIM5alpha consisting of the human RBCC domain followed by the B30.2 domain from various primates was constructed. These constructs showed restriction profiles largely consistent with the origin of the B30.2 domain. Restriction specificity was further investigated with a variety of TRIM5alphas containing mixed or mutated B30.2 domains. This study revealed the importance of all three variable regions for determining restriction specificity. Based on the molecular structures of other PRYSPRY domains solved recently, a model for the molecular structure of the B30.2 domain of TRIM5alpha was developed. The model revealed that the variable regions of the B30.2 domain are present as loops located on one side of the B30.2 core structure. It is hypothesized that these three loops form a binding surface for virus and that evolutionary changes in any one of the loops can alter restriction specificity.
Figures







Similar articles
-
The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.J Virol. 2005 May;79(10):6111-21. doi: 10.1128/JVI.79.10.6111-6121.2005. J Virol. 2005. PMID: 15857996 Free PMC article.
-
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.J Virol. 2005 Mar;79(5):3139-45. doi: 10.1128/JVI.79.5.3139-3145.2005. J Virol. 2005. PMID: 15709033 Free PMC article.
-
Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.J Virol. 2006 Jun;80(11):5631-6. doi: 10.1128/JVI.00219-06. J Virol. 2006. PMID: 16699044 Free PMC article.
-
The control of viral infection by tripartite motif proteins and cyclophilin A.Retrovirology. 2007 Jun 12;4:40. doi: 10.1186/1742-4690-4-40. Retrovirology. 2007. PMID: 17565686 Free PMC article. Review.
-
TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity.Viruses. 2024 Jun 21;16(7):997. doi: 10.3390/v16070997. Viruses. 2024. PMID: 39066160 Free PMC article. Review.
Cited by
-
Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5α.Virology. 2013 Jan 20;435(2):463-71. doi: 10.1016/j.virol.2012.09.042. Epub 2012 Oct 16. Virology. 2013. PMID: 23084420 Free PMC article.
-
A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5 alpha.Retrovirology. 2010 Jul 7;7:58. doi: 10.1186/1742-4690-7-58. Retrovirology. 2010. PMID: 20609213 Free PMC article.
-
Characterization of a core fragment of the rhesus monkey TRIM5α protein.BMC Biochem. 2011 Jan 4;12:1. doi: 10.1186/1471-2091-12-1. BMC Biochem. 2011. PMID: 21205312 Free PMC article.
-
Caging the beast: TRIM5α binding to the HIV-1 core.Viruses. 2011 May;3(5):423-8. doi: 10.3390/v3050423. Epub 2011 Apr 27. Viruses. 2011. PMID: 21994740 Free PMC article.
-
Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish.PLoS One. 2011;6(7):e22022. doi: 10.1371/journal.pone.0022022. Epub 2011 Jul 15. PLoS One. 2011. PMID: 21789205 Free PMC article.
References
-
- Bainbridge, J. W., C. Stephens, K. Parsley, C. Demaison, A. Halfyard, A. J. Thrasher, and R. R. Ali. 2001. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector: efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 8:1665-1668. - PubMed
-
- Benit, L., N. De Parseval, J. F. Casella, I. Callebaut, A. Cordonnier, and T. Heidmann. 1997. Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene. J. Virol. 71:5652-5657. - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources